José-Alain Sahel
corporate_vc
About
José-Alain Sahel is a French ophthalmologist and translational vision scientist who serves as Distinguished Professor and Chairman of Ophthalmology at the University of Pittsburgh School of Medicine and Director of the UPMC Vision Institute. He is a prominent retinal-disease researcher and entrepreneur who has co-founded multiple ophthalmology biotechs including SparingVision, GenSight Biologics, Pixium Vision, and Fovea Pharmaceuticals. Public sources place him in scientific, board, and advisory roles across retinal therapeutics, gene therapy, optogenetics, and vision-restoration organizations, including a Scientific Advisory Board connection to Biophytis in your database.
Areas of interest
ophthalmologyretinal degenerationvision restorationgene therapyoptogeneticsartificial retinabiotechtranslational medicinemedical devicesage-related retinal disease